These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 24755198)
21. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization. Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166 [TBL] [Abstract][Full Text] [Related]
22. Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma. Scholz SL; Möller I; Reis H; Süßkind D; van de Nes JAP; Leonardelli S; Schilling B; Livingstone E; Schimming T; Paschen A; Sucker A; Murali R; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3464-3470. PubMed ID: 28700778 [TBL] [Abstract][Full Text] [Related]
23. The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas. Appenzeller S; Gesierich A; Thiem A; Hufnagel A; Jessen C; Kneitz H; Regensburger M; Schmidt C; Zirkenbach V; Bischler T; Schilling B; Siedel C; Goebeler ME; Houben R; Schrama D; Gehrig A; Rost S; Maurus K; Bargou R; Rosenwald A; Schartl M; Goebeler M; Meierjohann S Cancer; 2019 Feb; 125(4):586-600. PubMed ID: 30561760 [TBL] [Abstract][Full Text] [Related]
24. Genomic and Clinicopathologic Characteristics of PRKAR1A-inactivated Melanomas: Toward Genetic Distinctions of Animal-type Melanoma/Pigment Synthesizing Melanoma. Cohen JN; Yeh I; Mully TW; LeBoit PE; McCalmont TH Am J Surg Pathol; 2020 Jun; 44(6):805-816. PubMed ID: 32118628 [TBL] [Abstract][Full Text] [Related]
25. Melanoma genomics - will we go beyond BRAF in clinics? Mirek J; Bal W; Olbryt M J Cancer Res Clin Oncol; 2024 Sep; 150(9):433. PubMed ID: 39340537 [TBL] [Abstract][Full Text] [Related]
26. Predominance of triple wild-type and IGF2R mutations in mucosal melanomas. Iida Y; Salomon MP; Hata K; Tran K; Ohe S; Griffiths CF; Hsu SC; Nelson N; Hoon DSB BMC Cancer; 2018 Oct; 18(1):1054. PubMed ID: 30373548 [TBL] [Abstract][Full Text] [Related]
27. The molecular profile of mucosal melanoma. Mikkelsen LH; Maag E; Andersen MK; Kruhøffer M; Larsen AC; Melchior LC; Toft PB; von Buchwald C; Wadt K; Heegaard S Melanoma Res; 2020 Dec; 30(6):533-542. PubMed ID: 33156594 [TBL] [Abstract][Full Text] [Related]
28. Melanocytic Skin Neoplasms: What Lesson From Genomic Aberrations? Urso C Am J Dermatopathol; 2019 Sep; 41(9):623-629. PubMed ID: 31433323 [TBL] [Abstract][Full Text] [Related]
39. The role of gene fusions in melanocytic neoplasms. Quan VL; Panah E; Zhang B; Shi K; Mohan LS; Gerami P J Cutan Pathol; 2019 Nov; 46(11):878-887. PubMed ID: 31152596 [TBL] [Abstract][Full Text] [Related]
40. Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance. Wheler J; Yelensky R; Falchook G; Kim KB; Hwu P; Tsimberidou AM; Stephens PJ; Hong D; Cronin MT; Kurzrock R BMC Cancer; 2015 Feb; 15():61. PubMed ID: 25886620 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]